According to filings with the U.S. Securities and Exchange Commission, Xevant is raising up to $9,072,553.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brandon Newman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Xevant
Xevant is a groundbreaking analytics platform that infuses real-time automation across the entire pharmacy benefits eco-system, driving lower costs and improving health. We understand your pain. In fact, we’ve been there. It’s the very reason we built the industry’s first automated data analytics and reporting platform for pharmacy benefit organizations. After spending more than 30 years building manual reports for Payers, PBMs, TPAs, Consultants, and Brokers, we created a game changing platform that autonomously compiles complete analyses, builds reports, and identifies specific client opportunities you can act on in a matter of minutes — not months. No more missed deadlines and questionable results. No more suffering with lengthy, risky methods. With extensive experience across the Pharmacy Benefits ecosystem, we deliver highly functional and personalized solutions that assist our clients to better navigate and compete in a complex and changing market. We achieve the lowest net healthcare cost through intelligent, real-time, automated technology.

To learn more about Xevant, visit http://www.xevant.com/

Contact:
Brandon Newman, Chief Executive Officer
888-774-5551
https://www.linkedin.com/in/brandonnewman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.